EY agrees, disagrees with statements in Dayton Power & Light's 8-K
The Dayton Power & Light Company submitted an unsigned letter in response to its July 27, 2026 form 8-K, with the auditor agreeing or disagreeing with specific statements from the …
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
The Dayton Power & Light Company submitted an unsigned letter in response to its July 27, 2026 form 8-K, with the auditor agreeing or disagreeing with specific statements from the …
Ernst & Young LLP responds to DPL's July 27, 2026, Form 8-K to confirm agreement with specific statements, while offering no opinion on the rest.
EY accountant firm issued an opinion letter agreeing with transaction statements on the submitted 8-K reporting document for July 27, 2026.
Kraft Heinz filed an amended and restated bylaw document which becomes effective July 22, 2026. This corporate governance update changes internal procedures for stockholder meeting…
The company filed an exhibit outlining the terms and conditions of its inducement equity incentive plan, designed to attract and retain employees.
On July 21, 2026, HPS Net Lease Income REIT filed an amended and restated declaration of trust that changes outstanding common shares into Class E Common Shares and governs the ent…
NYSE American accepted Picard Medical's plan to regain continued listing standards, extending the compliance period through November 2027. This decision protects the company's list…
Freenome's SimpleScreen CRC, a blood-based colorectal cancer screening test, received FDA approval and will be commercialized in the U.S. by Abbott to help millions of Americans wh…
Neumora Therapeutics reported positive preclinical toxicology data for its NLRP3 inhibitor NMRA-215. The results support the advancement of the drug candidate to the clinic. The co…
MapLight Therapeutics reported topline data from its Phase 2 ZEPHYR trial evaluating its schizophrenia candidate ML-007C-MA. The data release is critical for the company's clinical…
Surf Air Mobility Inc. received an NYSE notice due to a 30-day closing stock price averaging below $1.00. The company intends to regain compliance organically but could also consid…
Cycurion announced it requested a hearing to appeal Nasdaq's proposed delisting based on a minimum bid price requirement, with trading expected to continue temporarily while the co…
Outlook Therapeutics received FDA approval for LYTENAVA (bevacizumab-vikg), the first ophthalmic formulation of bevacizumab, targeting a significant portion of the wet AMD market.
Helio Corp. filed an Article of Amendment to restate its Articles of Incorporation pursuant to section 607.0120 of the Florida Statutes. The amendment also includes changes related…
Faraday Future Intelligent Electric Inc. filed the Twelfth Certificate of Amendment to its Third Amended and Restated Certificate of Incorporation. This administrative update docum…
AMR Resources Acquisition Corp filed its balance sheet as of July 20, 2026, showing a total asset value of $261.5 million. The date of the filing marks reportable financial figures…
RMX Industries filed a Certificate of Change with the Nevada Secretary of State on July 22, 2026, to amend its business entity information.
Taylor Morrison Home Corp filed an updated certificate of incorporation in Delaware. The filing amends the company's listing to conform with regulations effective Feb 20, 2024, upd…
Profound Medical announced data from its CAPTAIN trial where the TULSA Procedure demonstrated statistically significant superior penile length preservation compared to robotic radi…
NewAmsterdam and Menarini received a positive CHMP opinion patent dosing options for obicetrapib, pending further regulatory review.